Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Low iron levels are linked to more hair loss in non-menopausal women.

Early balding linked to higher heart disease risk.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Turmeric may improve knee osteoarthritis, depression, and metabolic syndrome, but evidence is weak.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Fiber implantation for baldness is not recommended because it causes many problems and doesn't work well.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Using the right hair care products can improve hair health and help manage hair disorders.

Ahmad's NPRT system accurately documents and predicts male pattern baldness.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.